Klapstein Julie D 4

What Happened

• Julie D. Klapstein, a director of Omada Health, was granted 10,882 restricted stock units (RSUs) on 2026-06-16. The Form 4 reports the award as acquired at $0.00 per share (aggregate $0) — these are RSUs that convert into one share of common stock per RSU upon vesting.

Key Details

• Transaction date: 2026-06-16 (reported on Form 4 filed 2026-06-18).
• Type/code: Grant/Award (Code A).
• Amount: 10,882 RSUs; Price reported: $0.00; Aggregate value at grant: $0.
• Vesting: Per the filing footnote, 100% of the RSUs vest on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2027 Annual Meeting, subject to continued service.
• Shares owned after transaction: Not specified in the provided filing.
• Filing timeliness: Form 4 filed two days after the grant date (appears timely).

Context

• RSUs are a compensatory award that convert to shares only upon vesting; no shares were sold or purchased in the open market. Such grants compensate or retain insiders and do not by themselves indicate immediate buying or selling sentiment. Upon vesting, shares may be subject to tax withholding or other conditions disclosed in future filings.